AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

296.64B

Market cap296.64B

Price-Earnings ratio

31.05

Price-Earnings ratio31.05

Dividend yield

1.63%

Dividend yield1.63%

Average volume

12.75M

Average volume12.75M

High today

$96.18

High today$96.18

Low today

$94.37

Low today$94.37

Open price

$94.66

Open price$94.66

Volume

7.05M

Volume7.05M

52 Week high

$96.51

52 Week high$96.51

52 Week low

$61.24

52 Week low$61.24

AZN News

TipRanks 8h

AstraZeneca’s AZD3974 Enters Early Human Testing: What Investors Should Watch

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools...

TipRanks 15h

AstraZeneca initiated with a Buy at Citi

Citi initiated coverage of AstraZeneca (AZN) with a Buy rating and 17,000 GBp price target The firm says the company has the “fastest” mid-term sales and earnin...

Yahoo Finance 1d

Drugmakers AstraZeneca, GSK to join Starmer delegation to China, sources say - Yahoo Finance

...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

6.5%

Sell

12.9%

More AZN News

TipRanks 1d

AstraZeneca Sharpens Andexanet Strategy With New Phase I Dosing Study

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview: AstraZeneca is running a Phase I study t...

TipRanks 1d

AstraZeneca Halts Early Heart Drug Study: What It Means for AZN Investors

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview: AstraZeneca is running an early-stage st...

TipRanks 5d

AstraZeneca Tests Capivasertib in Liver-Impaired Patients: What Investors Should Watch

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview: AstraZeneca is running a Phase I study c...

TipRanks 5d

AstraZeneca Ends Early-Stage Ceralasertib Combo Study: What Investors Should Know

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.